InvestSMART

Atomo Diagnostics Limited (ASX: AT1) - Share Price

- Current share price for AT1 : $0.018

Atomo Diagnostics Limited (AT1) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a Company that is engaged in development and sale of medical devices.

AT1 General Information +

ASX Code AT1
Website N/A
Industry/Sector Health Care Equipment
Market Cap ($M) 16
AT1 Share Price $0.018
Day High $0.018
Day Low $0.018
Last Close $0.018
AT1 Share Price Movement - ( No change )
Prices as at 16:40, 2 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Atomo Diagnostics Limited (AT1) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Atomo Diagnostics Limited (AT1) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Atomo Diagnostics Limited (AT1) price-sensitive announcements

AT1 - Managing Director & CEO Transition
Atomo Diagnostics Limited announced the transition of its leadership with John Kelly, the
Atomo Diagnostics Limited (AT1)
19 Aug 2026 | 9:55 AM
AT1 - Quarterly Activities/Appendix 4C Cash Flow Report
Atomo Diagnostics Limited reported strong financial performance for Q4 FY2026, with revenu
Atomo Diagnostics Limited (AT1)
23 Jul 2026 | 9:46 AM
AT1 - Share Purchase Plan Results
Atomo Diagnostics Limited announced the results of its Share Purchase Plan (SPP) which clo
Atomo Diagnostics Limited (AT1)
15 May 2026 | 11:06 AM
AT1 - Quarterly Activities/Appendix 4C Cash Flow Report
Atomo Diagnostics Limited, trading on the ASX as AT1, has reported its financial and opera
Atomo Diagnostics Limited (AT1)
28 Apr 2026 | 9:53 AM

Atomo Diagnostics Limited (AT1) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $16 2026 Appendix 4G and Corporate Governance Statement 31 Aug 2026 9:17AM $0.018 $0.018 fallen by 0%
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $16 FY26 Results Presentation 31 Aug 2026 9:15AM $0.018 $0.018 fallen by 0%
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $16 2026 Appendix 4E and Annual Report 31 Aug 2026 9:13AM $0.018 $0.018 fallen by 0%
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $16 Final Director's Interest Notice 19 Aug 2026 5:18PM $0.018 $0.018 fallen by 0%
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $16 Managing Director & CEO Transition 19 Aug 2026 9:55AM $0.018 $0.018 fallen by 0%
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $16 Quarterly Activities/Appendix 4C Cash Flow Report 23 Jul 2026 9:46AM $0.018 $0.018 fallen by 0%

AT1 Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$4.97 -$0.80 -19.00% 0.00 0.00 0.00% 0.0%
2024A -$6.05 -$1.00 -45.40% 0.00 0.00 0.00% 0.0%
2023A -$9.96 -$1.70 74.00% 0.00 0.00 0.00% 0.0%

AT1 Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Atomo Diagnostics Limited (AT1) $16M -0.1895 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Cochlear Limited (COH) $8,758M -0.3136 0.2540 0.0785 32.6038 25.9998 24.1076 2.58% 2.68% 2.91%
Fisher & Paykel Healthcare Corporation Limited (FPH) $21,371M 0.1388 0.1647 0.1748 54.9372 47.1696 40.1525 1.19% 1.29% 1.46%
ResMed Inc. (RMD) $19,538M 9.5922 0.0984 0.0886 21.4532 19.5306 17.9409 1.08% 1.18% 1.27%

AT1 Directors

Name Position Start Date
Dr Cheri Louise Walker Executive Director, Interim CEO 15 Nov 2022
Mr Anthony May Non-Executive Director 2 May 2025
Mr Patrick Cook Non-Executive Director 2 May 2025

Atomo Diagnostics Limited (AT1) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
27 Jun 2025 KELLY, John Issued Direct Shares 1,621,622 $0.018 $30,000.000
27 Jun 2025 MAY, Anthony Issued Indirect Shares 540,541 $0.018 $10,000.000
27 Jun 2025 COOK, Patrick Issued Indirect Shares 540,541 $0.018 $10,000.000

See all changes in directors' interest & trades for Atomo Diagnostics Limited (AT1) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

AT1 Management

Name Position
Chandra Sukumar Chief Operating Officer
Mathew Leslie Watkins Company Secretary

AT1 Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Atomo Diagnostics Limited (AT1). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
116,922,671 (14.43%) GZ Family Holdings Pty Ltd
74,111,870 (9.15%) John Kelly
64,392,433 (7.95%) Mr Xiaoyi Lin
61,570,716 (7.60%) Global Health Investment Fund LLC

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.